# Avail Medsystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avail-medsystems

- Industry: Software
- Headquarters: Palo Alto, US
- Website: www.avail.io
- Total disclosed funding: $127M
- Latest round: Series B (Sep 25, 2020)
- Investors on record: 8

## About

Avail Medsystems, Inc. specializes in innovative audio/visual systems designed to enhance surgical operations. Their technology facilitates real-time collaboration and remote participation, thereby improving efficiency in medical environments.Avail Medsystems, Inc. was founded in 2018 in Palo Alto, US. The company focuses on providing integrated audio/visual systems for the operating room. It has completed a total of 4 deals, with the most recent funding occurring in March 2024, where it raised USD 100.00 mn in a SERIES B round led by D1 Capital Partners, alongside other investors such as 8VC, Baidu Ventures, Coatue Management, Lux Capital, Playground Ventures, Refactor Capital, and Sonder Capital. As of now, the company has a current valuation of USD 263.975 mn. The CEO and founder is Daniel Hawkins.Avail Medsystems specializes in integrated audio/visual hardware and software systems designed to enhance operational efficiency in the medical field, specifically within the operating room (OR) environment. Their flagship product, the Avail System, serves as a digital hub that enables real-time collaboration and remote participation during surgical procedures. This technology facilitates remote consultations, knowledge sharing about surgical techniques, and collaboration among medical professionals. The company's solutions target hospitals, surgical centers, and R&D units in the MedTech industry, with notable clients such as Smith+Nephew and Great Plains Health Heart Institute. Avail Medsystems operates in the United States and Europe, expanding its reach to healthcare providers looking to optimize their surgical operations and enhance the capabilities of their medical teams.Avail Medsystems generates revenue through a subscription-based model, allowing healthcare institutions to access their telepresence technology and related services without upfront capital investment. Clients typically engage in partnerships with a recurring fee for access to the Avail System and its features, which include remote collaboration tools and hosting third-party clinical software applications within the OR environment. These partnerships streamline operational processes, facilitating improved efficiency and innovation in surgical practices.In March 2024, Mendaera, Inc. acquired Avail Medsystems, Inc., with financial terms undisclosed. The newly acquired company will utilize its recent funding to enhance its platform by integrating Avail's telepresence technology, enabling more efficient and accessible patient care solutions. Avail Medsystems aims to expand its market presence further, targeting additional healthcare sectors and geographic regions in the coming years.

## Funding rounds

- Series B, Sep 25, 2020, $100M — Lux Capital, Coatue Management, Playground Ventures, 8VC, Refactor Capital, Baidu Ventures, D1 Capital Partners, Sonder Capital
- Series A, Jan 14, 2020, $14M — Lux Capital, Coatue Management, Playground Ventures, Refactor Capital, Baidu Ventures, Sonder Capital
- Series A, May 16, 2018, $13M — Playground Ventures, Baidu Ventures

## Investors

- Playground Ventures (https://capitalatlas.ai/funds/playground-ventures) — Series A, Series B
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Series A, Series B
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series A, Series B
- Coatue Management (https://capitalatlas.ai/funds/coatue-management) — Series A, Series B
- Refactor Capital (https://capitalatlas.ai/funds/refactor-capital) — Series A, Series B
- Sonder Capital (https://capitalatlas.ai/funds/sonder-capital) — Series A, Series B
- 8VC (https://capitalatlas.ai/funds/8vc) — Series B
- D1 Capital Partners (https://capitalatlas.ai/funds/d1-capital-partners) — Series B